Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.

Exec Edge

2024-09-05

By Karen Roman

Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.

The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.

Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.

“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.

Contact:

Exec Edge

Editor@executives-edge.com

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2465826524"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2465826524\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2465826524?lang=zh_CN&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AO.04eMXeQXrFNkEWwWJ4Q--~B/aD02MTI7dz0yMTcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d","is_english":true,"pubTime":"2024-09-05 23:57","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2465826524","market":"us","top_or_hot":-1,"title":"Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.","media":"Exec Edge","content":"<html><body><p><img height=\"612\" src=\"https://s.yimg.com/uu/api/res/1.2/fs94hglSmggkAYEKO.PktA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d\" width=\"2170\"/></p>\n<p>By Karen Roman</p>\n<p>Biotechnology company Medera Inc. said it entered a definitive merger agreement with <a href=\"https://laohu8.com/S/KVACU\">Keen Vision Acquisition Corp.</a> (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.</p>\n<p>The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.</p>\n<p>Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.</p>\n<p>“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.</p>\n<p>Contact:</p>\n<div>\nExec Edge\n</div>\n<div>\n<p>Editor@executives-edge.com</p>\n</div>\n</body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-05 23:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html><strong>Exec Edge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Karen Roman\nBiotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial ...</p>\n\n<a href=\"https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":".IXIC","symbol_name":"NASDAQ Composite","start_time":0,"source_url":"https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html","article_id":"2465826524","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AO.04eMXeQXrFNkEWwWJ4Q--~B/aD02MTI7dz0yMTcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2465826524","pubTimestamp":1725551842,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. , with the combined company having an implied initial enterprise value of approximately $622.6 million.The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{".IXIC":"NASDAQ Composite","BK4588":"碎股","KVACU":"Keen Vision Acquisition Corp.","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","NDAQ":"纳斯达克OMX交易所","KVACW":"KEEN VISION ACQUISITION CORPORATION C/WTS 15/03/2028 (TO PUR ORD)","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","KVAC":"KEEN VISION ACQUISITION CORPORATION"},"translate_title":"Medera与Keen Vision Acquisition Corp合并后将在纳斯达克上市。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,"KVAC":0.9,"KVACU":1,"KVACW":0.9,"NDAQ":1},"content_text":"By Karen Roman\nBiotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.\nThe transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.\nMedera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.\n“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.\nContact:\n\nExec Edge\n\n\nEditor@executives-edge.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}